COMPANY:

Admera Health

"Admera Health...announced today that it has engaged Back Bay Life Science Advisors...to explore strategic alternatives for its pharmacogenomics and clinical services business as part of a company-wide strategic review. Admera offers the most comprehensive clinical PGx test in the industry, covering 62 genes, over 270 medications, and over 20 therapeutic areas, including:...oncology. Admera Health’s clinical services portfolio is built on a strong foundation of next-generation sequencing (NGS) and data analysis capabilities...OncoGxOne™...The product compliments Admera Health’s suite of NGS tests, spanning the continuum of cancer patient care."